Selpercatinib benefit, with or without pembro, in first-line advanced RET fusion-positive NSCLC

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer 

Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer

Adding nivolumab to neoadjuvant chemo improves response rate for high risk ER+ HER2− breast cancer

Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer

Belzutifan improves PFS, ORR in clear cell renal cell carcinoma

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC

Effects of short-term fasting on quality of life as an add-on option during chemotherapy

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for ccRCC

Genomic testing: Awareness and effective communication between healthcare professionals and patients